# Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks

> **NCT00986921** · NA · COMPLETED · sponsor: **Boston University** · enrollment: 50 (actual)

## Conditions studied

- Abortion

## Interventions

- **DRUG:** mifepristone 200 mg
- **DEVICE:** osmotic dilator insertion

## Key facts

- **NCT ID:** NCT00986921
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986921, "Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00986921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*